ACE2 and COVID-19: Despite the moderate ACE2 expression level in lungs, pneumonia is the primary symptom of COVID-19 patients, presumably because respiratory tract is the main transmission route.3 Accumulating evidence implicates the ACE2 expression in patients is positively related to the susceptibility to SARS-CoV-2, severity, and mortality.